Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 30 settembre?
Casi di morbillo negli Stati Uniti entro il 30 settembre?
NUOVO
30 set 2026
2900+
98%
3000+
94%
$1,253 Vol.
2900+
$940 Vol.
98%
3000+
$313 Vol.
94%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Aug 24, 2026, 11:00 AM ET
Volume
$1,253Data di fine
30 set 2026Mercato aperto
Aug 24, 2026, 11:00 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$1,253Data di fine
30 set 2026Mercato aperto
Aug 24, 2026, 11:00 AM ETResolver
0x65070BE91...Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti